351 related articles for article (PubMed ID: 18621038)
1. Early increases in serum S100B are associated with cerebral hemorrhage in a rat model of focal cerebral ischemia.
Tanaka Y; Marumo T; Omura T; Yoshida S
Brain Res; 2008 Aug; 1227():248-54. PubMed ID: 18621038
[TBL] [Abstract][Full Text] [Related]
2. Relationship between cerebrospinal and peripheral S100B levels after focal cerebral ischemia in rats.
Tanaka Y; Marumo T; Omura T; Yoshida S
Neurosci Lett; 2008 May; 436(1):40-3. PubMed ID: 18359161
[TBL] [Abstract][Full Text] [Related]
3. Serum S100B, brain edema, and hematoma formation in a rat model of collagenase-induced hemorrhagic stroke.
Tanaka Y; Marumo T; Shibuta H; Omura T; Yoshida S
Brain Res Bull; 2009 Mar; 78(4-5):158-63. PubMed ID: 19027832
[TBL] [Abstract][Full Text] [Related]
4. Serum S100B is a useful surrogate marker for long-term outcomes in photochemically-induced thrombotic stroke rat models.
Tanaka Y; Koizumi C; Marumo T; Omura T; Yoshida S
Life Sci; 2007 Aug; 81(8):657-63. PubMed ID: 17706250
[TBL] [Abstract][Full Text] [Related]
5. Glial and axonal body fluid biomarkers are related to infarct volume, severity, and outcome.
Petzold A; Michel P; Stock M; Schluep M
J Stroke Cerebrovasc Dis; 2008; 17(4):196-203. PubMed ID: 18589339
[TBL] [Abstract][Full Text] [Related]
6. The 5HT1A receptor agonist, 8-OH-DPAT, protects neurons and reduces astroglial reaction after ischemic damage caused by cortical devascularization.
Ramos AJ; Rubio MD; Defagot C; Hischberg L; Villar MJ; Brusco A
Brain Res; 2004 Dec; 1030(2):201-20. PubMed ID: 15571670
[TBL] [Abstract][Full Text] [Related]
7. Serum S100B indicates brain edema formation and predicts long-term neurological outcomes in rat transient middle cerebral artery occlusion model.
Tanaka Y; Koizumi C; Marumo T; Omura T; Yoshida S
Brain Res; 2007 Mar; 1137(1):140-5. PubMed ID: 17204253
[TBL] [Abstract][Full Text] [Related]
8. Serum tight-junction proteins predict hemorrhagic transformation in ischemic stroke patients.
Kazmierski R; Michalak S; Wencel-Warot A; Nowinski WL
Neurology; 2012 Oct; 79(16):1677-85. PubMed ID: 22993287
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction.
Foerch C; Singer OC; Neumann-Haefelin T; du Mesnil de Rochemont R; Steinmetz H; Sitzer M
Arch Neurol; 2005 Jul; 62(7):1130-4. PubMed ID: 16009772
[TBL] [Abstract][Full Text] [Related]
10. Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B.
Dassan P; Keir G; Brown MM
Cerebrovasc Dis; 2009; 27(3):295-302. PubMed ID: 19202335
[TBL] [Abstract][Full Text] [Related]
11. Serum S100B indicates successful combination treatment with recombinant tissue plasminogen activator and MK-801 in a rat model of embolic stroke.
Tanaka Y; Marumo T; Omura T; Yoshida S
Brain Res; 2007 Jun; 1154():194-9. PubMed ID: 17475227
[TBL] [Abstract][Full Text] [Related]
12. Circulating cerebral S100B protein is associated with depressive symptoms following myocardial infarction.
Tulner DM; Smith OR; de Jonge P; van Melle JP; Slomp J; Storm H; Quere M; den Boer JA; Honig A; Korf J
Neuropsychobiology; 2009; 59(2):87-95. PubMed ID: 19325251
[TBL] [Abstract][Full Text] [Related]
13. Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke.
Wunderlich MT; Wallesch CW; Goertler M
J Neurol Sci; 2004 Dec; 227(1):49-53. PubMed ID: 15546591
[TBL] [Abstract][Full Text] [Related]
14. [S100B: astrocyte specific protein].
Tateishi N; Shimoda T; Yada N; Shinagawa R; Kagamiishi Y
Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Feb; 26(1):11-6. PubMed ID: 16637591
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide protects against ischemic brain damage induced by focal cerebral ischemia in rats.
Yang J; Song TB; Zhao ZH; Qiu SD; Hu XD; Chang L
Brain Res; 2011 Jun; 1398():94-101. PubMed ID: 21620378
[TBL] [Abstract][Full Text] [Related]
16. [Changes of protein S100B serum concentration during ischemic and hemorrhagic stroke in relation to the volume of stroke lesion].
Weglewski A; Ryglewicz D; Mular A; Juryńczyk J
Neurol Neurochir Pol; 2005; 39(4):310-7. PubMed ID: 16096936
[TBL] [Abstract][Full Text] [Related]
17. Relationship between stress and circulating levels of S100B protein.
Scaccianoce S; Del Bianco P; Pannitteri G; Passarelli F
Brain Res; 2004 Apr; 1004(1-2):208-11. PubMed ID: 15033438
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of s100b and NSE in migraine.
Teepker M; Munk K; Mylius V; Haag A; Möller JC; Oertel WH; Schepelmann K
Headache; 2009 Feb; 49(2):245-52. PubMed ID: 18783450
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke.
Foerch C; Wunderlich MT; Dvorak F; Humpich M; Kahles T; Goertler M; Alvarez-Sabín J; Wallesch CW; Molina CA; Steinmetz H; Sitzer M; Montaner J
Stroke; 2007 Sep; 38(9):2491-5. PubMed ID: 17673718
[TBL] [Abstract][Full Text] [Related]
20. Plasma heart-type fatty acid binding protein level in acute ischemic stroke: comparative analysis with plasma S100B level for diagnosis of stroke and prediction of long-term clinical outcome.
Park SY; Kim MH; Kim OJ; Ahn HJ; Song JY; Jeong JY; Oh SH
Clin Neurol Neurosurg; 2013 Apr; 115(4):405-10. PubMed ID: 22766253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
